NCT01813461View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Pharmacokinetics of 14C-labeled IsavuconazoleHealthy Subjects
Interventions
DRUG

14C-labeled prodrug isavuconazonium sulfate

oral

Trial Locations (1)

53704

Covance, Madison

Sponsors
All Listed Sponsors
collaborator

Basilea Pharmaceutica International Ltd

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT01813461 - Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects | Biotech Hunter | Biotech Hunter